fda drug shortage list semaglutide status january 2025 Novo's Wegovy and Ozempic removed from US list, compounders on notice US judge upholds FDA's removal – GLP-1 Drugs: FDA Removes Semaglutide

Clinical Evidence on Oral GLP-1 Safety and Effectiveness The PIONEER program, a series of Phase 3 trials with over 4,600 participants, established oral semaglutide's safety profile and weight loss results

GLP-1 related dietary changes can reduce overall food intake, making consistent micronutrient absorption more challenging

An Other factors that can contribute to vitamins losing potency include: extreme temperatures exposure to light exposure to oxygen pH levels Unopened vitamin supplements are more likely to retain their potency because moisture, light, and oxygen are less likely to affect them

This avoids overlap, reduces side effects and gives the body time to adjust